Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 75,699Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 36BRISTOL

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

POMALIDOMIDE

US Patent Number : 8198262

Drug Substance Claim :

Drug Product Claim :

Application Number : 204026

Patent Use Code : U-1360

Delist Requested :

Patent Use Description : USE OF POMALIDOMIDE FO...

Patent Expiration Date : 2025-06-17

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

POMALIDOMIDE

US Patent Number : 8198262

Drug Substance Claim :

Drug Product Claim :

Application Number : 204026

Patent Use Code : U-2254

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-06-17

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

POMALIDOMIDE

US Patent Number : 8198262

Drug Substance Claim :

Drug Product Claim :

Application Number : 204026

Patent Use Code : U-2254

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-06-17

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

POMALIDOMIDE

US Patent Number : 8198262

Drug Substance Claim :

Drug Product Claim :

Application Number : 204026

Patent Use Code : U-1360

Delist Requested :

Patent Use Description : USE OF POMALIDOMIDE FO...

Patent Expiration Date : 2025-06-17

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

POMALIDOMIDE

US Patent Number : 8198262

Drug Substance Claim :

Drug Product Claim :

Application Number : 204026

Patent Use Code : U-2254

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-06-17

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

POMALIDOMIDE

US Patent Number : 8198262

Drug Substance Claim :

Drug Product Claim :

Application Number : 204026

Patent Use Code : U-1360

Delist Requested :

Patent Use Description : USE OF POMALIDOMIDE FO...

Patent Expiration Date : 2025-06-17

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

POMALIDOMIDE

US Patent Number : 8198262

Drug Substance Claim :

Drug Product Claim :

Application Number : 204026

Patent Use Code : U-2254

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-06-17

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

POMALIDOMIDE

US Patent Number : 8198262

Drug Substance Claim :

Drug Product Claim :

Application Number : 204026

Patent Use Code : U-1360

Delist Requested :

Patent Use Description : USE OF POMALIDOMIDE FO...

Patent Expiration Date : 2025-06-17

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

POMALIDOMIDE

US Patent Number : 8828427

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204026

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-06-21

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

POMALIDOMIDE

US Patent Number : 10555939

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204026

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-05-19

blank